Concomitant hydroxyurea and radiotherapy in the management of 60 patients with head and neck cancer.
D000328:Adult; D000368:Aged; D005260:Female; D005882:Gingival Diseases / Q000628:therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D008443:Maxillary Sinus; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010157:Palatal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014067:Tonsillar Neoplasms / Q000188:drug therapy / Q000532:radiotherapy
D006918:Hydroxyurea